Treating Depression Without Medication
Trinitas/St. Joseph's Behavioral Health Network introduces new approach
Depression is a widespread and often debilitating anomaly. It goes beyond temporary sadness and can last indefinitely, robbing one of quality of life if not rendering people of all ages completely dysfunctional. In fact, depression is the leading cause of disability worldwide, according to the Anxiety and Depression Association of America. People with depression often also suffer from anxiety disorders, which are different, but share similar symptoms like insomnia, the inability to concentrate, nervousness, and irritability.
If you’re one of the 15 million Americans with depression who either can’t tolerate, or don’t respond to medication, TMS therapy, a non-invasive treatment that uses magnetic fields to stimulate the brain, may be the antidote to your suffering.
FDA-cleared BrainsWay Deep TMS is a non-invasive treatment that stimulates the brain using magnetic fields similar to what is used for an MRI. The treatment has no systemic side effects and requires no hospitalization or anesthesia. To date, the therapy has been proven in more than 60 clinical trials worldwide.
The Trinitas-St. Joseph's Behavioral Health Network is partnering with HPR Treatment Centers (a division of TMS Centers of America) to offer TMS at two treatment facilities in Essex County by June, 2018, followed by another six sites throughout Northern NJ over the next year.
Despite being a newer treatment for depression, TMS is a proven option with impressive efficacy rates and research results.
"TMS is indicated for the treatment of adults with major depression who have not responded to at least one antidepressant," said Dr. Carlos Rueda, Chairman of Psychiatry for the Trinitas-St. Joseph's Behavioral Health Network. "We are excited to bring this therapy option to the residents of New Jersey, offering new hope for a complex condition."
"This partnership allows us to work with two of the leading medical institutions in the state to provide a comprehensive continuum of care to treat those suffering from depression," said Ben Klein, founder and CEO of HPR Treatment Centers. "We have been offering TMS to patients across the country and know firsthand the significant impact the treatment has on patients. We have seen people with depression who have lost hope regain it back when they achieve remission through TMS."
Half of the 15 million Americans with depression cannot tolerate or do not respond to antidepressant medication. And unlike medication, TMS has no systemic side effects and requires no hospitalization or anesthesia.
"Depression is believed to be caused by electrical dysfunction of one region of the brain, known as the dorsolateral prefrontal cortex,” adds Dr. Rueda. “Through a highly focused and targeted magnetic stimulation, we’re able to boost the function of the brain in this region, allowing for a remission of the depression."
Because TMS is a non-drug, non-invasive treatment, patients are awake during the procedure and can get back to daily activities, including driving, immediately following the session.
"We are excited to work with HPR Treatment Centers to help Trinitas and St. Joseph's deliver optimal mental health solutions to their patients and partner with them in this initiative that will address a growing challenge in treating mental health patients," said Joe Perekupka, vice president at BrainsWay. "We are fortunate to partner with HPR Treatment Centers, as they have demonstrated true leadership in increasing access to Deep TMS for patients across the country. By providing the tools necessary to help these renowned facilities treat patients who are suffering from mental disorders, we are enabling better outcomes for patients."
For more information or to make an appointment, call 631-807-5759.